BioSpace News Archive

Lipocine Inc. (Nasdaq: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced the U.S. Food and Drug Administration (“FDA”) has affirmed the resubmission of its New Drug Application (“NDA”) for TLANDO®, its oral testosterone product, will be a Class 1 resubmission.

Portal Instruments, developer of the Prime needle-free drug delivery platform, announced that a new clinical study demonstrating patient preference for Prime needle-free injections was published this month in the journal Drug Delivery.

Seagen Announces Last Patient Enrolled in Phase 2 MOUNTAINEER Trial Evaluating TUKYSA ® (Tucatinib) Regimen in HER2-Positive Metastatic Colorectal Cancer

Agilent Technologies Inc. (NYSE: A) today announced Professor Bernhard Lendl has been selected to receive a prestigious Agilent Thought Leader Award.

Sanofi announces positive Phase 1/2 study interim results for its first mRNA-based vaccine candidate

Stair lift, commonly used in home care settings or healthcare facilities, are motorized seats which run along a rail or track and are powered by alternating current or batteries so that they can function even during power outages.

Myelofibrosis is an uncommon type of bone marrow cancer and is related to a group of blood cancers known as myeloproliferative neoplasms.

Liver carries out important functions in the body such as protein production, metabolizing of fat & carbohydrate, and detoxification of drugs, alcohol, and environmental toxin.

The rising cases of hospital-acquired infections are a prime factor boosting the global infection surveillance solutions market.

As per the study published in NCBI or National Centre for Biotechnology Information, over 3.7 million people in Canada are living with varicose veins.